Entheogens, including cannabis, faced one of their most restrictive environments in the 20th century. Now, as attitudes shift, several countries are investing in research using psilocybin mushrooms, MDMA, Ketamine, and other substances previously listed as some of the most dangerous materials in the country. With this shift comes a new wave of technological opportunity, and companies are poised to offer these substances to the public.